Impact of the Change in ESC Guidelines on Clinical Characteristics and Outcomes of Cardiogenic Shock Patients Receiving IABP Therapy
Highlights
- • IABP implantation has declined overtime since the change in ESC guidelines.
- • After 2012, the IABP use is restricted to high-risk, severely compromised patients.
- • IABP for very unstable patients does not offer better outcomes.
- • IABP for mechanical support may improve clinical outcomes in selected patients.
Abstract
Background
Intra-aortic balloon pump (IABP) counterpulsation provides mechanical support for patients with cardiogenic shock. The aim of the study is to evaluate the clinical characteristics and outcomes of patients with cardiogenic shock receiving IABP before and after the European Society of Cardiology (ESC) downgraded the use of IABP from a class I to a class IIb in 2012.